Insmed, Inc. (INSM)
118.54
-2.85
(-2.35%)
USD |
NASDAQ |
Aug 28, 16:00
118.52
-0.02
(-0.02%)
After-Hours: 16:40
Insmed Total Return Price : 118.54 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 27, 2026 | 121.39 |
| August 26, 2026 | 124.39 |
| August 25, 2026 | 123.89 |
| August 24, 2026 | 123.98 |
| August 21, 2026 | 125.77 |
| August 20, 2026 | 125.08 |
| August 19, 2026 | 130.66 |
| August 18, 2026 | 128.46 |
| August 17, 2026 | 128.32 |
| August 14, 2026 | 123.74 |
| August 13, 2026 | 126.33 |
| August 12, 2026 | 132.28 |
| August 11, 2026 | 132.57 |
| August 10, 2026 | 134.75 |
| August 07, 2026 | 131.10 |
| August 06, 2026 | 132.55 |
| August 05, 2026 | 99.02 |
| August 04, 2026 | 98.75 |
| August 03, 2026 | 98.45 |
| July 31, 2026 | 98.60 |
| July 30, 2026 | 101.49 |
| July 29, 2026 | 103.12 |
| July 28, 2026 | 104.13 |
| July 27, 2026 | 104.73 |
| July 24, 2026 | 106.92 |
| Date | Value |
|---|---|
| July 23, 2026 | 107.41 |
| July 22, 2026 | 106.64 |
| July 21, 2026 | 108.62 |
| July 20, 2026 | 107.02 |
| July 17, 2026 | 108.32 |
| July 16, 2026 | 107.46 |
| July 15, 2026 | 109.81 |
| July 14, 2026 | 110.11 |
| July 13, 2026 | 109.14 |
| July 10, 2026 | 115.61 |
| July 09, 2026 | 118.26 |
| July 08, 2026 | 116.53 |
| July 07, 2026 | 112.84 |
| July 06, 2026 | 111.54 |
| July 02, 2026 | 111.60 |
| July 01, 2026 | 107.00 |
| June 30, 2026 | 106.62 |
| June 29, 2026 | 104.74 |
| June 26, 2026 | 103.38 |
| June 25, 2026 | 104.47 |
| June 24, 2026 | 103.46 |
| June 23, 2026 | 102.15 |
| June 22, 2026 | 98.60 |
| June 18, 2026 | 95.80 |
| June 17, 2026 | 98.45 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 237.00 |
| United Therapeutics Corp. | 515.31 |
| ACADIA Pharmaceuticals, Inc. | 29.12 |
| Biogen, Inc. | 218.66 |
| Gilead Sciences, Inc. | 145.70 |